Rarely Heard: Fabry Disease Takeda Pharmaceuticals

In this last episode, let’s summarise what we have learnt about Fabry disease and consolidate the valuable tips and advice our guest speakers have shared.
 
This podcast is initiated and funded by Takeda Pharmaceuticals and intended for an international audience outside the USA. The speakers may have received honoraria from Takeda for their participation, and the views expressed reflect the experience and opinion of the speaker. This podcast is available for information purposes only; it is not intended to replace the need for medical consultations. For further information and advice, please consult your healthcare provider. The impact and symptoms of Fabry disease described in this podcast are based on individual patient experience and may not be applicable to all patients with Fabry disease. Individual experience may vary. VV-MEDMAT-77431 (date of preparation: February 2023).

Hosted on Acast. See acast.com/privacy for more information.

Navigating the rare disease environment can be daunting for patients. In this episode, we are joined by Dr Berthold Wilden, who explains how patient organisations can support families living with Fabry disease.
 
This podcast is initiated and funded by Takeda Pharmaceuticals and intended for an international audience outside the USA. The speakers may have received honoraria from Takeda for their participation, and the views expressed reflect the experience and opinion of the speaker. This podcast is available for information purposes only; it is not intended to replace the need for medical consultations. For further information and advice, please consult your healthcare provider. The impact and symptoms of Fabry disease described in this podcast are based on individual patient experience and may not be applicable to all patients with Fabry disease. Individual experience may vary. VV-MEDMAT-77430 (date of preparation: February 2023).

Hosted on Acast. See acast.com/privacy for more information.

Genetic counselling can help patients and families affected by Fabry disease to understand the inheritance of the disease and identify at-risk family members. In this episode, Martynas is joined by Dr Charles Lourenço to explore what it involves and share practical advice on how it can support patients and their families.
 
This podcast is initiated and funded by Takeda Pharmaceuticals and intended for an international audience outside the USA. The speakers may have received honoraria from Takeda for their participation, and the views expressed reflect the experience and opinion of the speaker. This podcast is available for information purposes only; it is not intended to replace the need for medical consultations. For further information and advice, please consult your healthcare provider. The impact and symptoms of Fabry disease described in this podcast are based on individual patient experience and may not be applicable to all patients with Fabry disease. Individual experience may vary. VV-MEDMAT-77429 (date of preparation: February 2023).

Hosted on Acast. See acast.com/privacy for more information.

In this episode, Martynas and Dr Charles Lourenço share the challenges and their knowledge of navigating daily life with Fabry disease.
 
This podcast is initiated and funded by Takeda Pharmaceuticals and intended for an international audience outside the USA. The speakers may have received honoraria from Takeda for their participation, and the views expressed reflect the experience and opinion of the speaker. This podcast is available for information purposes only; it is not intended to replace the need for medical consultations. For further information and advice, please consult your healthcare provider. The impact and symptoms of Fabry disease described in this podcast are based on individual patient experience and may not be applicable to all patients with Fabry disease. Individual experience may vary. VV-MEDMAT-77428 (date of preparation: February 2023).

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we first talk with Dr Berthold Wilden, then we speak with Martynas, both of whom are patients living with Fabry disease. They will tell us about their life with Fabry disease and share insights and advice on managing the psychological effects of living with a rare disease. We will also hear how patient organisations can step in to support families with their mental health and emotional wellbeing.
 
This podcast is initiated and funded by Takeda Pharmaceuticals and intended for an international audience outside the USA. The speakers may have received honoraria from Takeda for their participation, and the views expressed reflect the experience and opinion of the speaker. This podcast is available for information purposes only; it is not intended to replace the need for medical consultations. For further information and advice, please consult your healthcare provider. The impact and symptoms of Fabry disease described in this podcast are based on individual patient experience and may not be applicable to all patients with Fabry disease. Individual experience may vary. VV-MEDMAT-77427 (date of preparation: February 2023).

Hosted on Acast. See acast.com/privacy for more information.

In this episode, we first talk with Martynas, a patient living with Fabry disease, then we hear from Dr Charles Denaro. They will share their experiences and tips on managing chronic pain, fatigue, and the neurological aspects of the disease.
 
This podcast is initiated and funded by Takeda Pharmaceuticals and intended for an international audience outside the USA. The speakers may have received honoraria from Takeda for their participation, and the views expressed reflect the experience and opinion of the speaker. This podcast is available for information purposes only; it is not intended to replace the need for medical consultations. For further information and advice, please consult your healthcare provider. The impact and symptoms of Fabry disease described in this podcast are based on individual patient experience and may not be applicable to all patients with Fabry disease. Individual experience may vary. VV-MEDMAT-77425 (date of preparation: February 2023).

Hosted on Acast. See acast.com/privacy for more information.